Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.08.2019 / 10:52 The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Title: First name: Gregory Last name(s): Hamilton 2. Reason for […]
Year: 2019
12. August 2019
DGAP-DD: Epigenomics AG deutsch
Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 12.08.2019 / 10:48 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 1. Angaben zu den Personen, die Führungsaufgaben wahrnehmen, sowie zu den in enger Beziehung zu ihnen stehenden Personen a) Name Titel: Vorname: […]
12. August 2019
DGAP-DD: Epigenomics AG deutsch
Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 12.08.2019 / 10:52 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 1. Angaben zu den Personen, die Führungsaufgaben wahrnehmen, sowie zu den in enger Beziehung zu ihnen stehenden Personen a) Name Titel: Vorname: […]
07. August 2019
Epigenomics AG Highlights Operational Achievements and Reports Financial Results for First Six Months 2019
DGAP-News: Epigenomics AG / Key word(s): Half Year Results/Quarter Results 07.08.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Highlights Operational Achievements and Reports Financial Results for First Six Months 2019 Berlin (Germany) and San Diego, CA (U.S.A.), August 7, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, […]
05. August 2019
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG 05.08.2019 / 12:11 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 […]
24. July 2019
Study Published in American Health Drug Benefits Suggests that Non-Invasive Screening Methods, Including Epi proColon, Could Be A Cost-Effective Option To Help Achieve Target U.S. Colorectal Cancer Screening Rates
DGAP-News: Epigenomics AG / Key word(s): Study results/Study 24.07.2019 / 21:42 The issuer is solely responsible for the content of this announcement. Study Published in American Health Drug Benefits Suggests that Non-Invasive Screening Methods, Including Epi proColon, Could Be A Cost-Effective Option To Help Achieve Target U.S. Colorectal Cancer Screening Rates Berlin, 24 July 2019 […]